Stay updated on XmAb20717 in Biliary Cancers Clinical Trial
Sign up to get notified when there's something new on the XmAb20717 in Biliary Cancers Clinical Trial page.

Latest updates to the XmAb20717 in Biliary Cancers Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record history shows the addition of revision v3.5.0 and the deletion of revision v3.4.3.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe change adds revision v3.4.3 and removes revision v3.4.2 from the record history.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added to the record history. The page also removes the notices about government funding and the prior Revision: v3.4.1.SummaryDifference0.8%

- Check62 days agoChange DetectedNotice regarding a lapse in government funding is added to the page. The update note shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.8%

- Check69 days agoChange DetectedAdded a Show glossary option and color-coded indicators for additions and deletions, and updated the revision label to v3.4.0 with No FEAR Act data removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check105 days agoChange DetectedThe history now lists a new 'Revision: v3.3.3' entry and removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer, which are routine maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to XmAb20717 in Biliary Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb20717 in Biliary Cancers Clinical Trial page.